|Top Previous Next|
1. Monitoring parameters:
Obtain at steady-state (approximately four half lives) and then weekly during therapy.
Measure every two days, or every day in unstable renal function.
Weigh patient every two to seven days.
Measure and monitor urine output daily.
2. Therapeutic serum concentrations (mcg/ml)
Although considerable controversy exists, the following target serum levels are currently recommended: